{"log_id": 9115140515420973541, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 2e-06, "average": 0.998817, "min": 0.996263}, "location": {"width": 115, "top": 184, "height": 27, "left": 192}, "words": "【儿童用药】"}, {"probability": {"variance": 2e-06, "average": 0.998941, "min": 0.994646}, "location": {"width": 542, "top": 230, "height": 28, "left": 226}, "words": "儿童用药的安全性与有效性尚未建立。本品不推荐用于儿童"}, {"probability": {"variance": 1.9e-05, "average": 0.997548, "min": 0.987946}, "location": {"width": 116, "top": 281, "height": 25, "left": 202}, "words": "【老年用药】"}, {"probability": {"variance": 3.6e-05, "average": 0.996262, "min": 0.981829}, "location": {"width": 145, "top": 329, "height": 27, "left": 228}, "words": "见【用法用量】"}, {"probability": {"variance": 1.1e-05, "average": 0.997523, "min": 0.990374}, "location": {"width": 158, "top": 376, "height": 26, "left": 193}, "words": "【药物相互作用】"}, {"probability": {"variance": 1e-06, "average": 0.998924, "min": 0.997339}, "location": {"width": 86, "top": 424, "height": 25, "left": 227}, "words": "尚不明确"}, {"probability": {"variance": 1.3e-05, "average": 0.998411, "min": 0.981506}, "location": {"width": 784, "top": 465, "height": 34, "left": 228}, "words": "目前出现了同时使用两种前列素类似物滴眼液出现眼内压反常升高的报告。所以,不推"}, {"probability": {"variance": 2e-06, "average": 0.999252, "min": 0.991633}, "location": {"width": 626, "top": 514, "height": 32, "left": 186}, "words": "荐同时使用两种或多种前列腺素、前列腺素类似物或前列腺素衍生物"}, {"probability": {"variance": 0, "average": 0.999185, "min": 0.998733}, "location": {"width": 115, "top": 566, "height": 24, "left": 193}, "words": "【药物过量】"}, {"probability": {"variance": 5e-06, "average": 0.998591, "min": 0.988899}, "location": {"width": 648, "top": 608, "height": 31, "left": 228}, "words": "本品过量滴眼,除了眼睛刺激和结膜充血外,尚未发现其它眼部副作用"}, {"probability": {"variance": 4e-06, "average": 0.998486, "min": 0.993154}, "location": {"width": 786, "top": 653, "height": 34, "left": 226}, "words": "若意外误服本品,请注意以下信息:每瓶滴眼液含拉坦前列素125微克,90%以上的拉"}, {"probability": {"variance": 0.002551, "average": 0.990049, "min": 0.664859}, "location": {"width": 826, "top": 702, "height": 33, "left": 186}, "words": "坦前列素首过肝脏时即被代谢。健康志愿者静脉注射拉坦前列素3μg/kg无任何症状,但55"}, {"probability": {"variance": 0.000999, "average": 0.992978, "min": 0.800625}, "location": {"width": 799, "top": 747, "height": 36, "left": 212}, "words": "0μgkg可引起恶心、腹痛、头晕、疲劳感、潮热和出汗。猴静脉输注拉坦前列素高达"}, {"probability": {"variance": 0.009554, "average": 0.973006, "min": 0.558906}, "location": {"width": 332, "top": 797, "height": 33, "left": 193}, "words": "00ug/kg也无明显的心血管系统作用"}, {"probability": {"variance": 0.000241, "average": 0.996373, "min": 0.902831}, "location": {"width": 784, "top": 841, "height": 33, "left": 228}, "words": "猴静脉给予拉坦前列素可引起短暂的支气管收缩。但中度支气管哮喘病人眼部使用本品"}, {"probability": {"variance": 1e-06, "average": 0.999197, "min": 0.994983}, "location": {"width": 606, "top": 890, "height": 31, "left": 186}, "words": "剂量达临床剂量7倍时,也没有拉坦前列素引起的支气管收缩效应"}, {"probability": {"variance": 0, "average": 0.999695, "min": 0.999018}, "location": {"width": 273, "top": 941, "height": 26, "left": 228}, "words": "若发生药物过量,请对症治疗"}, {"probability": {"variance": 0, "average": 0.999131, "min": 0.997914}, "location": {"width": 116, "top": 990, "height": 23, "left": 193}, "words": "【药理毒理】"}, {"probability": {"variance": 9e-06, "average": 0.997144, "min": 0.992249}, "location": {"width": 185, "top": 1022, "height": 40, "left": 190}, "words": "药理作用广"}, {"probability": {"variance": 0.000326, "average": 0.994444, "min": 0.888842}, "location": {"width": 763, "top": 1075, "height": 35, "left": 230}, "words": "活性成份拉坦前列素为前列腺素F2的类似物,是一种选择性前列腺素FP受体激动剂"}, {"probability": {"variance": 0.008281, "average": 0.977517, "min": 0.541015}, "location": {"width": 824, "top": 1124, "height": 30, "left": 187}, "words": "能通过增加房水流出而降低眼压。在人类,降低眼压约从给药后3-4小时开始,8-12小"}, {"probability": {"variance": 1.1e-05, "average": 0.998549, "min": 0.979151}, "location": {"width": 827, "top": 1168, "height": 34, "left": 186}, "words": "时达到最大作用。降眼压作用至少可维持24小时。动物和人类的研究均显示药物主要作用"}, {"probability": {"variance": 2e-05, "average": 0.998532, "min": 0.970954}, "location": {"width": 827, "top": 1215, "height": 35, "left": 186}, "words": "机制为增加房水的葡萄膜巩膜旁道流出,虽然在人类也有报道轻微增加了房水流出的便利度"}, {"probability": {"variance": 0.002546, "average": 0.974513, "min": 0.843098}, "location": {"width": 157, "top": 1269, "height": 26, "left": 197}, "words": "(减少引流阻力)"}, {"probability": {"variance": 1e-05, "average": 0.998546, "min": 0.98194}, "location": {"width": 786, "top": 1309, "height": 34, "left": 228}, "words": "主要的临床研究证明本品单药治疗有效。此外还进行了联合用药的临床研究,这些研究"}, {"probability": {"variance": 0.002123, "average": 0.98363, "min": 0.786568}, "location": {"width": 827, "top": 1356, "height": 35, "left": 187}, "words": "显示拉坦前列素与β一肾上腺素阻断剂(噻吗洛尔)合用有效。短期研究(1或2周)显示"}, {"probability": {"variance": 7.7e-05, "average": 0.994757, "min": 0.960236}, "location": {"width": 826, "top": 1405, "height": 30, "left": 187}, "words": "拉坦前列素与肾上腺素激动剂( dipivalyl epinephrine)、口服碳酸酐酶抑制剂(乙酰唑胺)合"}, {"probability": {"variance": 2e-06, "average": 0.998904, "min": 0.993843}, "location": {"width": 608, "top": 1451, "height": 34, "left": 187}, "words": "用效果叠加,与胆碱激动剂(毛果芸香碱)合用效果至少部分叠加"}, {"probability": {"variance": 9e-06, "average": 0.998657, "min": 0.982467}, "location": {"width": 772, "top": 1497, "height": 33, "left": 229}, "words": "临床研究还显示拉坦前列素对房水的产生无明显影响,对血液一房水屏障无任何作用"}, {"probability": {"variance": 1.5e-05, "average": 0.998359, "min": 0.978059}, "location": {"width": 786, "top": 1545, "height": 33, "left": 228}, "words": "按临床剂量使用以及在猴子的研究中,拉坦前列素对眼内的血循环无影响或影响可忽略"}], "language": 3}